Nonutility of procalcitonin for diagnosing bacterial pneumonia in patients with severe COVID-19

ABSTRACTBackground Patients hospitalized with COVID-19 are at significant risk for superimposed bacterial pneumonia. However, diagnosing superinfection is challenging due to its clinical resemblance to severe COVID-19. We therefore evaluated whether the immune biomarker, procalcitonin, could facilit...

Full description

Bibliographic Details

Published in:	European Clinical Respiratory Journal
Main Authors:	Avi J. Cohen, Laura R. Glick, Seohyuk Lee, Yukiko Kunitomo, Derek A. Tsang, Sarah Pitafi, Patricia Valda Toro, Nicholas R. Ristic, Ethan Zhang, George B. Carey, Rupak Datta, Charles S. Dela Cruz, Samir Gautam
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2023-01-01
Subjects:	COVID-19 procalcitonin critical care bacterial superinfection pneumonia biomarker
Online Access:	https://www.tandfonline.com/doi/10.1080/20018525.2023.2174640